Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 36(10): 1153-1163, 2018 10.
Article
in En
| MEDLINE
| ID: mdl-29600384
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Technology Assessment, Biomedical
/
Antineoplastic Combined Chemotherapy Protocols
/
Cost-Benefit Analysis
/
Paclitaxel
/
Deoxycytidine
Type of study:
Clinical_trials
/
Guideline
/
Health_economic_evaluation
/
Health_technology_assessment
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2018
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
New Zealand